XL-protein xl-protein.com


XL-protein, a biopharmaceutical company, commercializes PASylation technology that allows the extension of the plasma half-life of biopharmaceuticals in Germany.

XL-protein, a biopharmaceutical company, commercializes PASylation technology that allows the extension of the plasma half-life of biopharmaceuticals in Germany.

Company (Alive / Active)

Phone: +49 (0) 8161 53730-90

Fax:

Lise-Meitner-Str. 30

 Freising, 85354
 Germany

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
XL-protein $0M Apr 7, 2021

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related XL-protein Jobs

jobs by Indeed job search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Biosynthetic proline/alanine random coil polypeptides and their uses Aug 21, 2018 Nov 24, 2020 Patent
Modified l-asparaginase Aug 07, 2017 Jan 08, 2019 Patent
Conjugates of protein drugs and p/a peptides Jun 21, 2018 Application
Nucleic acids encoding repetitive amino acid sequences rich in proline and alanine residues that have low repetitive nucleotide sequences Dec 22, 2016 Application